Plasma Cell Labeling Index
Part of the
Methods in Molecular Medicine™
book series (MIMM, volume 113)
Multiple myeloma is characterized by proliferation of monoclonal plasma cells (PCs), mostly in the bone marrow. The proliferative rate of the malignant plasma cell is an important determinant of the disease biology and can be measured as the percentage of PCs in the S-phase of the cell cycle. This percentage, or PC labeling index, can be measured using a slide-based immuno- fluorescence method using an antibody against 5-bromo-2′-deoxyuridine, which is actively incorporated by DNA of the dividing PCs. This technique, which can be performed using bone marrow or peripheral blood specimens, also utilizes concurrent cytoplasmic staining against immunoglobulin as well as κ and λ light chains. Employment of cytoplasmic immunoglobulin staining allows more specific identification of PCs as well as confirmation of the monoclonal nature of the PC population. The staining procedure, which can be done manually or using an automated stainer, as well as the process of reading and interpreting these slides is described in detail. The bone marrow peripheral blood labeling index is an important clinical test, providing valuable diagnostic and prognostic information.
Key WordsMultiple myeloma plasma cell cell proliferation bromodeoxyuridine cell cycle immuno-fluorescence microscopy cell kinetics labeling index
Witzig T. E., Gonchoroff N. J., Katzmann J. A., Therneau T. M., Kyle R. A., and Greipp P. R. (1988) Peripheral blood B cell labeling indices are a measure of disease activity in patients with monoclonal gammopathies. J. Clin. Oncol.
, 1041–1046.PubMedGoogle Scholar
Greipp P. R., Witzig T. E., and Gonchoroff N. J. (1985) Immunofluorescent plasma cell labeling indices (LI) using a monoclonal antibody (BU-1). Am. J. Hematol.
, 289–292.PubMedCrossRefGoogle Scholar
Greipp P. R. and Kyle R. A. (1983) Clinical, morphological, and cell kinetic differences among multiple myeloma, monoclonal gammopathy of undetermined significance, and smoldering multiple myeloma. Blood
, 166–171.PubMedGoogle Scholar
Gonchoroff N. J., Katzmann J. A., Currie R. M., et al. (1986) S-phase detection with an antibody to bromodeoxyuridine: role of DNase pretreatment. J. Immunol. Methods
, 97–101.PubMedCrossRefGoogle Scholar
Witzig T. E., Dhodapkar M. V., Kyle R. A., and Greipp P. R. (1993) Quantitation of circulating peripheral blood plasma cells and their relationship to disease activity in patients with multiple myeloma. Cancer
, 108–113.PubMedCrossRefGoogle Scholar
Greipp P. R., Witzig T. E., Gonchoroff N. J., et al. (1987) Immunofluorescence labeling indices in myeloma and related monoclonal gammopathies. Mayo Clin. Proc.
, 969–977.PubMedGoogle Scholar
Witzig T. E., Gonchoroff N. J., Ahmann G. A., Katzmann J. A., and Greipp P. R. (1991) T cell depletion using anti-CD2 coated magnetic beads simplifies the detection of peripheral blood plasma cells. J. Immunol. Methods
, 253–256.PubMedCrossRefGoogle Scholar
Durie B. G., Salmon S. E., and Moon T. E. (1980) Pretreatment tumor mass, cell kinetics, and prognosis in multiple myeloma. Blood
, 364–372.PubMedGoogle Scholar
Greipp P. R., Katzmann J. A., O’Fallon W. M., and Kyle R. A. (1988) Value of beta 2-microglobulin level and plasma cell labeling indices as prognostic factors in patients with newly diagnosed myeloma. Blood
, 219–223.PubMedGoogle Scholar
Greipp P. R., Lust J. A., O’Fallon W. M., Katzmann J. A., Witzig T. E., and Kyle R. A. (1993) Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma. Blood
, 3382–3387.PubMedGoogle Scholar
Pettersson D., Mellstedt H., and Holm G. (1980) Monoclonal B lymphocytes in multiple myeloma. Scand. J. Immunol.
, 375–382.PubMedCrossRefGoogle Scholar
Witzig T. E., Kimlinger T. K., Ahmann G. J., Katzmann J. A., and Greipp P. R. (1996) Detection of myeloma cells in the peripheral blood by flow cytometry. Cytometry
, 113–120.PubMedCrossRefGoogle Scholar
Billadeau D., Greipp P., Ahmann G., Witzig T., and Van Ness B. (1995) Detection of B-cells clonally related to the tumor population in multiple myeloma and MGUS. Curr. Top. Microbiol. Immunol.
, 9–16.PubMedGoogle Scholar
Berenson J., Wong R., Kim K., Brown N., and Lichtenstein A. (1987) Evidence for peripheral blood B lymphocyte but not T lymphocyte involvement in multiple myeloma. Blood
, 1550–1553.PubMedGoogle Scholar